Загрузка...
Challenges encountered with argatroban anticoagulation during cardiopulmonary bypass
Use of argatroban as an alternative to heparin during cardiopulmonary bypass (CPB) in patients with heparin-induced thrombocytopenia has gained some attention in the past two decades. Dosing of argatroban during CPB is complex due to lack of complete understanding of its pharmacokinetic profile and...
Сохранить в:
| Главные авторы: | , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Medknow Publications & Media Pvt Ltd
2012
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3275940/ https://ncbi.nlm.nih.gov/pubmed/22345956 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/0970-9185.92458 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|